QLS2404
/ Qilu Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 08, 2026
A Study of QLS2404 Injection in Healthy Participants and Participants With Rheumatic Autoimmune Diseases
(clinicaltrials.gov)
- P1 | N=64 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.
New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
1 to 1
Of
1
Go to page
1